Hyperthyroidism and production of precocious involution in the mammary glands of lactating rats.
This study investigated the influence of chronic hyperthyroidism on mammary function in lactating rats and the effects on their pups. Thyroxine-treated (10 microg per 100 g body weight per day; hyperthyroid (HT)) or vehicle-treated rats were mated 2 weeks after the start of treatment and killed with their litters on days 7, 14 and 21 of lactation. Serum concentrations of triiodothyronine (T(3)) and tetraiodothyronine (T(4)) increased in thyroxine-treated rats. In HT mothers, serum prolactin decreased on day 7 and day 14 of lactation, whereas insulin-like growth factor I (IGF-I) and progesterone concentrations decreased, and corticosterone increased on day 7 of lactation. In HT pups, T(4) concentration increased on day 7 and day 14 of lactation, whereas T(3) increased only on day 14 of lactation, and growth hormone increased on day 7 of lactation. Mammary prolactin binding sites did not vary, but there was an increase in the binding sites in the liver on day 14 of lactation in thyroxine-treated rats. In an acute suckling experiment, thyroxine-treated rats released less oxytocin, growth hormone and prolactin and excreted less milk than did control rats. Mammary casein, lactose and total lipid concentrations in thyroxine-treated rats were similar to those of control rats on day 14 of lactation. Histological studies of the mammary glands showed an increased proportion of alveoli showing reduced or no lumina and cells with condensed nuclei on day 14 and day 21 of lactation; the TdT-mediated dUTP nick-end labelling (TUNEL) test revealed an increase in apoptosis in alveolar cells on day 21 of lactation in thyroxine-treated rats. Expression of SGP-2, a gene expressed during mammary involution, increased in thyroxine-treated rats on day 14 and day 21 of lactation, whereas expression of insulin-like growth factor binding protein 5, a proapoptotic signal, was unchanged. Bcl-2, which promotes survival of mammary gland epithelial cells was unchanged, whereas expression of IGF-I, which also promotes survival of mammary gland epithelial cells, increased on day 21 of lactation in thyroxine-treated rats. These results indicate that thyroxine treatment produces some milk stasis as a result of impairments in suckling induced release of oxytocin that may initiate the first stage of mammary involution, increasing apoptosis in a gland that is otherwise actively producing and secreting milk.
Varas
S M
SM
Laboratorio de Bioquímica Molecular, Departamento de Bioquímica y Ciencias Biológicas, Facultad de Química, Bioquímica y Farmacia, Universidad Nacional de San Luis, 5700 San Luis, Argentina.
Muñoz
E M
EM
Hapon
M B
MB
Aguilera Merlo
C I
CI
Giménez
M S
MS
Jahn
G A
GA
D000818:Animals; D000833:Animals, Suckling / Q000097:blood* / Q000254:growth & development; D017209:Apoptosis; D001665:Binding Sites; D002908:Chronic Disease; D051152:Clusterin; D005260:Female; D006023:Glycoproteins / Q000235:genetics; D013006:Growth Hormone / Q000097:blood; D006980:Hyperthyroidism / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology*; D020287:In Situ Nick-End Labeling; D018975:Insulin-Like Growth Factor Binding Protein 5 / Q000235:genetics; D007334:Insulin-Like Growth Factor I / Q000032:analysis; D008099:Liver / Q000378:metabolism; D008321:Mammary Glands, Animal / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology*; D008856:Microscopy, Fluorescence; D008893:Milk Ejection; D018832:Molecular Chaperones / Q000235:genetics; D010121:Oxytocin / Q000097:blood; D011247:Pregnancy; D011248:Pregnancy Complications / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology*; D011374:Progesterone / Q000097:blood; D011388:Prolactin / Q000378:metabolism; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013974:Thyroxine / Q000097:blood; D014284:Triiodothyronine / Q000097:blood
D051152:Clusterin; D006023:Glycoproteins; D018975:Insulin-Like Growth Factor Binding Protein 5; D018832:Molecular Chaperones; D012333:RNA, Messenger; D014284:Triiodothyronine; D011374:Progesterone; D010121:Oxytocin; D007334:Insulin-Like Growth Factor I; D011388:Prolactin; D013006:Growth Hormone; D013974:Thyroxine